10.6% in the liraglutide and placebo groups, respectively [12]
[19] [20] The decision to use both therapies should be individualized, considering the patient's complete medical history, current health status, and treatment goals
Retatrutide Research Compound 20mg Vial product details Retatrutide Research Compound 20mg Vial product-information listing 20mg research-use-only vial format Product image, pack details, price, and support information shown before enquiry This listing is provided for product-information review Online checkout is not enabled for this listing Supplied strictly for laboratory research use only
Patients who arent fully meeting their health goals with either therapy alone may find the combination worth discussing with a clinician
PubMed Wani S, Weskamp C, Marple J, Spry L